U.S. Neurosurgical Holdings, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 14, 2019 at 04:41 pm EST
Share
U.S. NeuroSurgical Holdings, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was USD 658,000 compared to USD 803,000 a year ago. Operating income was USD 292,000 compared to USD 29,000 a year ago. Net income was USD 115,000 compared to net loss of USD 120,000 a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to basic loss per share from continuing operations of USD 0.02 a year ago. For the nine months, sales was USD 2.324 million compared to USD 2.789 million a year ago. Operating income was USD 1.115 million compared to USD 593,000 a year ago. Net income was USD 242,000 compared to USD 19,000 a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to USD 0 a year ago.
U.S. NeuroSurgical Holdings, Inc., through its wholly-owned subsidiaries, holds interests in radiological treatment facilities. The Company owns and operates stereotactic radiosurgery centers, utilizing gamma knife technology. It owns, or holds interests in, the gamma knife and radiation treatment centers, and charges the hospital or medical facility, where the unit is housed and maintained, based on utilization. It is also focused on developing cancer centers featuring radiation therapy. These centers utilize linear accelerators with Intensity Modulated Radiation Therapy and Image Guided Radiation Therapy capabilities. It is focused on launching and development of Medicare advantage plans for seniors by its subsidiaries, Elite Health Plan and Elite Health Plan of Nevada, Inc. Medicare is the federal health insurance program for people ages 65 and over, to cover people under 65 with certain disabilities and people with end-stage renal disease requiring dialysis or kidney transplant.
U.S. NEUROSURGICAL HOLDINGS, INC. 
